The initial function of KLF4 as a tumour suppressor (for example, gastric tissue-specific deletion of KLF4 in mice triggers gastric hyperplasia and polyps55) was attributed to its transcriptional activation of cyclin-dependent kinase inhibitors such as p21, p27 and p57 (ref. 7). This evidence concerns the gene CDKN1A and neoplasm.